A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

Clinical trial NCT06767683 · RECRUITING

Trial details

NCT number: NCT06767683
Sponsor: Alkermes, Inc.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Narcolepsy Type 1 Narcolepsy Type 2 Idiopathic Hypersomnia

Start date: 2025-01-27
Primary completion: 2028-06-01
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.